{
    "clinical_study": {
        "@rank": "3117", 
        "arm_group": [
            {
                "arm_group_label": "Sham", 
                "arm_group_type": "Sham Comparator", 
                "description": "No stimulation transcorneal electrostimulation"
            }, 
            {
                "arm_group_label": "150%", 
                "arm_group_type": "Experimental", 
                "description": "transcorneal electrostimulation with 150% of phosphene threshold"
            }, 
            {
                "arm_group_label": "200%", 
                "arm_group_type": "Experimental", 
                "description": "transcorneal electrostimulation with 200% of phosphene threshold"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine the long term effects of transcorneal\n      electrostimulation (TES) in patients with retinitis pigmentosa (RP). In a prior study\n      (NCT00804102) the results of short term stimulation pointed to a positive effect on the\n      visual field and other parameters. In this study, the patients will be stimulated with\n      either 0%, 150% or 200% of the individually determined phosphene threshold."
        }, 
        "brief_title": "Transcorneal Electrostimulation for Therapy of Retinitis Pigmentosa", 
        "completion_date": {
            "#text": "February 2014", 
            "@type": "Actual"
        }, 
        "condition": "Retinitis Pigmentosa", 
        "condition_browse": {
            "mesh_term": [
                "Retinitis", 
                "Retinitis Pigmentosa"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  BCVA 0.02 to 0.9\n\n          -  reliable visual field measurements\n\n          -  reliable ERG measurements\n\n          -  skillful enough to use the device at home\n\n          -  able to give consent and take part during the whole study\n\n        Exclusion Criteria:\n\n          -  diabetic retinopathy\n\n          -  neovascularisation of any origin\n\n          -  after arterial or venous occlusion\n\n          -  after retinal detachment\n\n          -  silicone oil tamponade\n\n          -  dry or exudative age-related macular degeneration\n\n          -  macular edema\n\n          -  all forms of glaucoma\n\n          -  any form of corneal degeneration that reduces visual acuity\n\n          -  systemic diseases that are difficult to control or manage, that could endanger the\n             normal study schedule\n\n          -  patients in a permanently poor general condition, which could hinder the regular\n             attendance at control examinations in the clinic\n\n          -  forms of mental illness related to the bipolar affective and schizoid-affective\n             disorders, and all forms of dementia\n\n          -  simultaneous participation in another interventional study or history of\n             interventions whose effect may still persist"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "55", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "April 9, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01837901", 
            "org_study_id": "EST_2"
        }, 
        "intervention": {
            "arm_group_label": [
                "Sham", 
                "150%", 
                "200%"
            ], 
            "description": "OkuStim is used to determine the phosphene threshold, and then to administer electrostimulation", 
            "intervention_name": "transcorneal electrostimulation", 
            "intervention_type": "Device", 
            "other_name": [
                "OkuStim", 
                "TES"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": "transcorneal electrostimulation", 
        "lastchanged_date": "April 28, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "T\u00fcbingen", 
                    "country": "Germany", 
                    "zip": "72076"
                }, 
                "name": "Department f\u00fcr Augenheilkunde, Eberhard-Karls-Universit\u00e4t"
            }
        }, 
        "location_countries": {
            "country": "Germany"
        }, 
        "number_of_arms": "3", 
        "official_title": "Transkorneale Elektrostimulation Zur Therapie Bei Retinitis Pigmentosa - Eine Prospektive, Randomisierte, Einfach Blinde Folgestudie", 
        "overall_official": {
            "affiliation": "Eberhard-Karls-Universit\u00e4t T\u00fcbingen", 
            "last_name": "Florian Gekeler, Prof. Dr.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Germany: Federal Institute for Drugs and Medical Devices", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "August 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Change in the area measured by kinetic visual field measurement", 
            "measure": "Visual Field", 
            "safety_issue": "No", 
            "time_frame": "one year"
        }, 
        "reference": [
            {
                "PMID": "23049087", 
                "citation": "Naycheva L, Schatz A, R\u00f6ck T, Willmann G, Messias A, Bartz-Schmidt KU, Zrenner E, Gekeler F. Phosphene thresholds elicited by transcorneal electrical stimulation in healthy subjects and patients with retinal diseases. Invest Ophthalmol Vis Sci. 2012 Nov 1;53(12):7440-8. doi: 10.1167/iovs.12-9612."
            }, 
            {
                "PMID": "22350549", 
                "citation": "Gekeler F; Arbeitsgruppe Elektrostimulation des Department f\u00fcr Augenheilkunde am Universit\u00e4ts-Klinikum T\u00fcbingen. [Transcorneal electrostimulation]. Ophthalmologe. 2012 Feb;109(2):129-35. doi: 10.1007/s00347-011-2450-6. German."
            }, 
            {
                "PMID": "21467183", 
                "citation": "Schatz A, R\u00f6ck T, Naycheva L, Willmann G, Wilhelm B, Peters T, Bartz-Schmidt KU, Zrenner E, Messias A, Gekeler F. Transcorneal electrical stimulation for patients with retinitis pigmentosa: a prospective, randomized, sham-controlled exploratory study. Invest Ophthalmol Vis Sci. 2011 Jun 23;52(7):4485-96. doi: 10.1167/iovs.10-6932."
            }, 
            {
                "PMID": "22807300", 
                "citation": "Schatz A, Arango-Gonzalez B, Fischer D, Enderle H, Bolz S, R\u00f6ck T, Naycheva L, Grimm C, Messias A, Zrenner E, Bartz-Schmidt KU, Willmann G, Gekeler F. Transcorneal electrical stimulation shows neuroprotective effects in retinas of light-exposed rats. Invest Ophthalmol Vis Sci. 2012 Aug 15;53(9):5552-61. doi: 10.1167/iovs.12-10037."
            }, 
            {
                "PMID": "23329121", 
                "citation": "R\u00f6ck T, Schatz A, Naycheva L, Gosheva M, Pach J, Wilhelm B, Peters T, Bartz-Schmidt KU, Zrenner E, Willmann G, Gekeler F. [Effects of transcorneal electrical stimulation in patients with Stargardt's disease]. Ophthalmologe. 2013 Jan;110(1):68-73. doi: 10.1007/s00347-012-2749-y. German."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01837901"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "ERG b-wave", 
                "safety_issue": "No", 
                "time_frame": "one year"
            }, 
            {
                "measure": "ERG a-wave", 
                "safety_issue": "No", 
                "time_frame": "one year"
            }, 
            {
                "description": "Best corrected visual acuity", 
                "measure": "BCVA", 
                "safety_issue": "No", 
                "time_frame": "one Year"
            }, 
            {
                "description": "Visual Function Questionnaire (VFQ-25)", 
                "measure": "VFQ-25", 
                "safety_issue": "No", 
                "time_frame": "one year"
            }, 
            {
                "description": "Adaption time, changes in pupil diameter, threshold to fullfield blue and red light is measured with a fullfield stimulus threshold test (FST) on the ESPION ERG machine (Diagnosys).", 
                "measure": "Dark adaption", 
                "safety_issue": "No", 
                "time_frame": "one year"
            }
        ], 
        "source": "Okuvision GmbH", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Okuvision GmbH", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "July 2011", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}